BeStock  
Stocks › Biotechnology › ALMS

Alumis ALMS

US equityMarket cap rank #3330Biotechnology
$6.77 −$0.16 (-2.31%)
Pre-market · Oct 8, 9:10 am ET · After hours $6.77 0.00%
Open$6.82
Prev close$6.93
Day range$6.71 – $6.95
Volume2.17M
Market cap$876.28M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$1.66M-37.7% YoY
Operating profit-$107.03M+23.8% YoY
Net profit-$142.22M-339.7% YoY
Diluted EPS-$1.11-244.2% YoY
Free cash flow-$81.74M+23.6% YoY
Operating cash flow-$81.50M

Revenue, last 8 quarters

$0.0Sep '24$0.0Dec '24$17.4MMar '25$2.7MJun '25$2.1MSep '25$1.9MDec '25$1.7MMar '26$1.7MJun '26

Net profit, last 8 quarters

$-93.1MSep '24$-94.8MDec '24$-99.0MMar '25$59.3MJun '25$-110.8MSep '25$-92.9MDec '25$-93.1MMar '26$-142.2MJun '26

Diluted EPS by quarter

-1.73Sep '24-1.74Dec '24-1.82Mar '250.77Jun '25-1.06Sep '25-0.94Dec '25-0.74Mar '26-1.11Jun '26

Free cash flow by quarter

$-84.5MSep '24$-75.1MDec '24$-80.4MMar '25$-107.0MJun '25$-110.9MSep '25$-71.9MDec '25$-87.2MMar '26$-81.7MJun '26

Annual revenue

$0.0FY22$0.0FY23$0.0FY24$24.1MFY25

Profitability & balance sheet

Operating margin-5,639.1%
Net margin-5,933.5%
Return on equity-93.6%
Return on assets-74.9%
Return on invested capital-90.3%
Current ratio6.74
Liabilities / assets19.3%
Cash & investments$502.29M
Total debt$31.61M
Net cash (debt)$470.69M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $1.66M $1.74M $24.05M $1.93M $2.07M
Total Operating Revenue $1.66M $1.74M $24.05M $1.93M $2.07M
Operating Expense $108.69M $100.15M $477.85M $98.37M $117.36M
Selling and Admin Expenses $23.36M $18.61M $91.86M $15.59M $19.52M
-General & Admin Expense $23.36M $18.61M $91.86M $15.59M $19.52M
Research & Development $85.34M $81.54M $386.00M $82.79M $97.84M
Operating Profit -$107.03M -$98.41M -$453.80M -$96.45M -$115.29M
Net Non-Operating Interest Income (Expense) $4.95M $5.35M $14.18M $3.55M $4.59M
Non-Operating Interest Income $4.95M $5.35M $14.18M $3.55M $4.59M
Other Income (Expense) -$41.90M $7,000.00 $187.74M -$33,000.00 -$54,000.00
Special Income (Charges) -$41.82M – $187.91M $0.00 $0.00
-Less:Restructuring and Mergern & Acquisition $0.00 – -$187.91M $0.00 $0.00
-Less:Impairment of Capital Assets $41.82M – – – –
Other Non-Operating Income (Expenses) -$71,000.00 $7,000.00 -$169,000.00 -$33,000.00 -$54,000.00
Pretax Profit -$143.98M -$93.05M -$251.89M -$92.93M -$110.75M
Tax -$1.76M – -$8.56M $0.00 $0.00
Net Profit -$142.22M -$93.05M -$243.33M -$92.93M -$110.75M
Profit from Continuing Operations -$142.22M -$93.05M -$243.33M -$92.93M -$110.75M
Net Income to Parent Company -$142.22M -$93.05M -$243.33M -$92.93M -$110.75M
Net Income to Common Stockholders -$142.22M -$93.05M -$243.33M -$92.93M -$110.75M
Basic EPS -$1.11 -$0.74 -$2.86 -$0.94 -$1.06
Diluted EPS -$1.11 -$0.74 -$2.86 -$0.94 -$1.06

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $560.62M $671.59M $411.94M $411.94M $488.01M
Total Current Assets $514.08M $532.41M $318.23M $318.23M $393.29M
Cash and Cash Equivalents & Short-Term Investments $502.29M $522.94M $308.50M $308.50M $377.72M
-Cash and Cash Equivalents $63.71M $63.89M $89.67M $89.67M $65.26M
-Short Term Investments $438.59M $459.06M $218.83M $218.83M $312.47M
Receivables $3.86M $2.73M $2.08M $2.08M $3.64M
-Accrued Interest Receivable $2.09M $2.23M $1.34M $1.34M $1.99M
-Taxes Receivable $1.05M $499,000.00 $740,000.00 $740,000.00 $1.65M
-Other Receivables $724,000.00 – – – –
Prepaid Assets $6.95M $5.99M $6.42M $6.42M $10.93M
Restricted Cash $0.00 $86,000.00 $82,000.00 $82,000.00 –
Other Current Assets $978,000.00 $659,000.00 $1.14M $1.14M $1.00M
Total Non-Current Assets $46.53M $139.18M $93.71M $93.71M $94.72M
Net PPE $34.12M $33.49M $35.16M $35.16M $36.57M
-Gross PPE $43.85M $42.35M $43.15M $43.15M $43.69M
-Accumulated Depreciation -$9.73M -$8.86M -$7.99M -$7.99M -$7.12M
Goodwill and Other Intangible Assets $9.14M $50.96M $50.96M $50.96M $50.96M
Other Non-Current Assets $3.28M $8.13M $7.59M $7.59M $7.20M
Total Liabilities $108.46M $104.57M $110.64M $110.64M $103.24M
Total Current Liabilities $76.23M $70.90M $73.32M $73.32M $65.42M
Payables $12.80M $11.59M $10.11M $10.11M $4.55M
-Accounts Payable $12.80M $11.59M $10.11M $10.11M $4.55M
Current Accrued Expenses $51.94M $48.55M $56.84M $56.84M $55.08M
Short-Term Debt and Capital Lease Obligation $4.82M $4.44M $4.67M $4.67M $4.41M
-Current Capital Lease Obligation $4.82M $4.44M $4.67M $4.67M $4.41M
Current Deferred Liabilities $6.67M $6.33M $1.46M $1.46M –
Total Non-Current Liabilities $32.23M $33.66M $37.33M $37.33M $37.83M
Long Term Debt and Capital Lease Obligation $31.61M $31.22M $32.24M $32.24M $33.39M
-Long Term Capital Lease Obligation $31.61M $31.22M $32.24M $32.24M $33.39M
Non-Current Deferred Liabilities $383,000.00 $2.14M $4.75M $4.75M $4.08M
Other Non-Current Liabilities $239,000.00 $301,000.00 $330,000.00 $330,000.00 $356,000.00
Total Equity $452.16M $567.02M $301.30M $301.30M $384.77M
Stockholders' Equity $452.16M $567.02M $301.30M $301.30M $384.77M
Capital Stock $12,000.00 $12,000.00 $10,000.00 $10,000.00 $10,000.00
-Common Stock $12,000.00 $12,000.00 $10,000.00 $10,000.00 $10,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.59B $1.56B $1.20B $1.20B $1.19B
Retained Earnings -$1.14B -$994.93M -$901.88M -$901.88M -$808.95M
Gains/Losses Not Affecting Retained Earnings -$683,000.00 -$467,000.00 $188,000.00 $188,000.00 $234,000.00
Investments and Advances – $46.60M – – –
-Available for Sale Securities – $46.60M – – –
Convertible preferred securities – – – – $0.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$81.50M -$87.08M -$369.52M -$71.91M -$110.91M
Net cash flow from continuing operations -$81.50M -$87.08M -$369.52M -$71.91M -$110.91M
Net Income from Continuing Operations -$142.22M -$93.05M -$243.33M -$92.93M -$110.75M
Depreciation & Depletion & Amortization $874,000.00 $871,000.00 $3.50M $867,000.00 $916,000.00
Other Non-Cash Items $516,000.00 $575,000.00 -$186.21M $540,000.00 $537,000.00
Change in Working Capital $5.31M -$6.30M $17.76M $12.93M -$10.20M
-Change in Prepaid Assets -$1.76M $344,000.00 $28.70M $5.93M $15.30M
-Change in Payables and Accrued Expense $2.90M -$7.11M -$6.47M $6.18M -$20.51M
-Change in Other Current Assets $4.94M -$545,000.00 -$5.54M -$462,000.00 -$3.35M
-Change in Other Current Liabilities -$1.11M -$1.25M -$3.01M -$845,000.00 -$979,000.00
-Change In Other Working Capital $341,000.00 $2.26M $4.07M $2.13M -$667,000.00
Net cash flow from investing $68.69M -$285.69M $287.88M $95.01M $24.04M
Net Cash Flow from Continuing Investing Activities $68.69M -$285.69M $287.88M $95.01M $24.04M
Net PPE Purchase and Sale -$237,000.00 -$164,000.00 -$653,000.00 $0.00 $0.00
Net Investment Purchase and Sale $68.93M -$285.52M $238.79M $95.01M $24.04M
Financing Cash Flow $12.63M $346.99M $2.07M $1.32M $0.00
Net Cash Flow from Continuing Financing Activities $12.63M $346.99M $2.07M $1.32M $0.00
Net Common Stock Issuance $1.57M $323.80M $0.00 $0.00 -$749,000.00
Proceeds from Stock Option Exercised $11.06M $23.19M $2.07M $1.32M $749,000.00
Ending Cash Balance $65.09M $65.27M $91.05M $91.05M $66.63M
Net Change in Cash -$179,000.00 -$25.78M -$79.58M $24.42M -$86.87M
Beginning Cash Balance $65.27M $91.05M $170.63M $66.63M $153.50M
Free Cash Flow -$81.74M -$87.25M -$370.18M -$71.91M -$110.91M
Net Other Investing Changes – – $49.74M $0.00 $0.00
Net Preferred Stock Issuance – – $0.00 $0.00 –

Discussion

No comments yet — be the first to weigh in on ALMS.

Leave a comment

Scroll to Top